Chris Viehbacher's efforts to reinvigorate Biogen are continuing to take shape with the appointment of industry veteran Jane Grogan to the position of head of research.
Moderna and Pfizer have both said that updated versions of their COVID-19 vaccines work against the highly mutated BA.2.86 variant, also known as Pirola, which is being cl
Illumina has appointed Agilent Technologies executive Jacob Thaysen as its new chief executive, following the departure of former CEO Francis deSouza in June and chairman
Seagen and Genmab's antibody-drug conjugate Tivdak has been shown to improve overall survival when used as a second-line monotherapy for recurrent or metastatic cervical c
Italfarmaco's marketing application for HDAC inhibitor givinostat as a treatment for Duchenne muscular dystrophy (DMD) has been accepted by the EMA, setting up an approval